A Randomized, Pilot Study to Evaluate the Tolerability of OnabotulinumtoxinA Plus Topiramate vs. OnabotulinumtoxinA Plus Placebo and Long Term Effect of Treatment on Cognitive Efficiency and Continuation of Care
Phase of Trial: Phase IV
Latest Information Update: 29 Oct 2015
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Topiramate (Primary)
- Indications Migraine
- Focus Adverse reactions; Therapeutic Use
- 14 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Oct 2012 New trial record